glp-1 drugs shortage As Drug Ends, Why Will Patients Pay More? RECAP: Recent Updates in the

Because if protein, supplements, coaching, strength training, CGMs, or nutrition programs can improve GLP-1 outcomes, reduce side effects, or help people maintain results after discontinuation That is not just wellness. That is evidence worth generating

Moreover, it remains to be shown that GIPR agonism can improve insulin secretion in type 2 diabetic patients who have been noted in previous studies to be unresponsive to GIP

GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes

Secondary outcomes included time below and above the therapeutic range and INR variability

If you purchase through our links, we may earn a commission at no extra cost to you

Research, analysis, and narrative by Senior Associate Sarah Grant